NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 1, 2026 — Quantum BioPharma executive Anthony Durkacz discusses Lucid-MS for multiple sclerosis and unbuzzd alcohol metabolism accelerator on BioMedWire Podcast. Learn about the company's strategy and innovations.
July 1, 2026 — Cardio Diagnostics Holdings (CDIO) presents precision cardiovascular solutions at national conferences, using AI and epigenetics for early detection and cost management in healthcare.
July 1, 2026 — HeartBeam (NASDAQ: BEAT) advances cardiac care with the FDA-cleared HeartBeam System, a portable cable-free ECG that synthesizes 12-lead data for arrhythmia detection outside hospitals.
July 1, 2026 — Extreme heat is the leading weather-related cause of death in the U.S., straining the heart. The American Heart Association warns of rising risks and offers tips to stay safe. Learn about heat stroke, exhaustion, and how to protect your heart.
July 1, 2026 — Discover how antibody-drug conjugate and T-cell engager deals are creating value early. VERAXA Biotech (VRXA) leverages its platform for strategic partnerships in cancer therapy.
July 1, 2026 — American Heart Association announces volunteer leaders for 2026-27, including new president Dr. Manesh Patel and chairperson Lee Shapiro. Learn about their roles in advancing heart health.
July 1, 2026 — Quantum BioPharma (QNTM) executive Anthony Durkacz discusses Lucid-MS and unbuzzd in BioMedWire Podcast, revealing strategy for multiple sclerosis drug and alcohol metabolism accelerator.
July 1, 2026 — Annovis Bio (NYSE: ANVS) promotes Dr. Cheng Fang to chief scientific officer as it advances buntanetap toward Phase 3 Alzheimer's data and NDA submission.
July 1, 2026 — Onco-Innovations announces CAD$5M private placement to advance ONC010 program and SynoGraph platform for cancer treatment. Key players include ONCO, ONNVF, and InvestorWire.
July 1, 2026 — Onco-Innovations initiates polymer development for ONC010 nanoparticle PNKP inhibitor with Nanosoft Polymers, advancing scalable manufacturing for solid tumor cancer therapy.
July 1, 2026 — GeoVax Labs reports on U.S. government smallpox vaccine procurement, reinforcing domestic vaccine manufacturing and biodefense. GEO-MVA program advances for mpox and smallpox.
July 1, 2026 — LataMed AI partners with CANTV to expand digital healthcare in Venezuela, leveraging telecom infrastructure to improve access to telehealth and AI-driven health services.
July 1, 2026 — Pulmonary mesh nebulizers market to grow from $1.2B (2026) to $3.8B (2036) at 12.2% CAGR. Driven by home care shift, chronic disease rise, and smart tech. Key players: Aerogen, PARI, Philips. Read more.
July 1, 2026 — Protheragen Obesity offers precision preclinical models for next-gen obesity drugs, including gene-edited and in vitro cell models, to improve clinical translation and reduce trial failures.
July 1, 2026 — Nhu Truong expands grief therapy for Millennials and Gen Z, addressing friendship breakups, identity shifts, and more. Learn how her practice offers a broader understanding of loss.
July 1, 2026 — Nashville Concierge Medicines announces new diabetes care content featuring GLP-1 semaglutide. Learn how a private doctor in Nashville offers holistic, personalized treatment for diabetes and blood sugar management.
July 1, 2026 — The global disposable endoscope valves market is set to grow from USD 0.6B in 2026 to USD 1.1B by 2036, driven by infection prevention and rising endoscopy volumes. Key players include Olympus and Boston Scientific.
June 30, 2026 — Helix BioPharma appoints Helen Middleton as General Counsel and David Browning as VP of Clinical Operations, advancing L-DOS47 for lung cancer and preparing for U.S. listing.
June 30, 2026 — HeartBeam (BEAT) completes ALIGN-ACS pilot study enrollment ahead of schedule for heart attack detection using 3D ECG technology. Results may support FDA submission and expanded indication.
June 30, 2026 — Cardio Diagnostics Holdings (NASDAQ: CDIO) presents AI-powered precision medicine for cardiovascular disease prevention and risk assessment at national benefits conferences.